Stocktoria
COLGATE PALMOLIVE CO CL
COLGATE PALMOLIVE CO (CL) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $20.4B at a 10.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.01 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-03 | UBS | Buy (main) |
| 2026-08-03 | TD Cowen | Hold (main) |
| 2026-08-03 | JP Morgan | Overweight (main) |
| 2026-08-03 | RBC Capital | Outperform (main) |
| 2026-08-03 | Evercore ISI Group | Outperform (main) |
| 2026-07-21 | Barclays | Equal-Weight (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | -0.07 |
| Retained earnings / assets | 1.629 |
| EBIT / assets | 0.202 |
| Equity / liabilities | 0.023 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CL | COLGATE PALMOLIVE CO | 4/9 | 6.23 | 34.6 | +1.4% |
| KVUE | Kenvue Inc. | 5/9 | 1.21 | 25 | -2.1% |
| EL | ESTEE LAUDER COMPANIES INC | 4/9 | 2.44 | — | -8.2% |
| COTY | COTY INC. | 5/9 | -1.14 | — | -3.7% |
| EPC | EDGEWELL PERSONAL CARE Co | 5/9 | 2.61 | 50.3 | -1.3% |
| ELF | e.l.f. Beauty, Inc. | 3/9 | 2.18 | 152.3 | +24.6% |
| IPAR | INTERPARFUMS INC | 5/9 | 8.09 | 20.5 | +2.5% |
About COLGATE PALMOLIVE CO
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
FAQ
Is CL financially healthy?
COLGATE PALMOLIVE CO's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does CL pay a dividend?
No, COLGATE PALMOLIVE CO does not currently pay a dividend.
How profitable is CL?
In FY2025, COLGATE PALMOLIVE CO had a net margin of 10.5% and a return on equity of 584.1%.
Is CL overvalued or undervalued?
COLGATE PALMOLIVE CO trades at about 35.1× trailing earnings — above its 10-year norm (10-year range 23.5×–35.0×, median 30.4×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CL?
The average Wall-Street price target for COLGATE PALMOLIVE CO is $98.95, about 7.2% above the recent price, from 20 analysts (consensus: buy).
Is CL a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on COLGATE PALMOLIVE CO: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a P/E of about 34.6×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.